Research on prostate cancer has revealed that CA phenethyl ester can prevent NF-κB activation in prostate cancer-3 (PC-3) cells by preventing TNF-α and Paclitaxel from activating NF-κB. Here, NFKB1 is linked to prostate carcinoma.